Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nature’s Sunshine Prod. (NATR), Herbalife Ltd. (HLF) : A Huge Insider Buy of This Nutritional Product Direct Seller

Among the three, Nature’s Sunshine Prod. (NASDAQ:NATR) is the least profitable company as it generated the lowest operating margin at 9.26%. While the operating margin of Nu Skin is 15.7%, Herbalife Ltd. (NYSE:HLF) generates the highest operating margin at 16.2%. Nature’s Sunshine pays shareholders a dividend yield of 1% while the dividend yield of Nu Skin is 2.1%. Herbalife offers the juiciest yield among the three, at 2.9%.

At the end of 2012, Bill Ackman, a famous hedge fund manager, presented his bear case on Herbalife Ltd. (NYSE:HLF), saying that the company was a pyramid scheme. However, activist investor Carl Icahn did not believe so. Icahn has aggressively increased his stake in the company. By May 7, it was reported that he was the biggest shareholder of Herbalife, with a 15.5% stake in the company.

My Foolish takeaway

With the lowest EV multiple, conservative leverage, improving operating performance and recent huge insider buy, Nature’s Sunshine Prod. (NASDAQ:NATR) seems to be a decent stock for long-term investors.

The article A Huge Insider Buy of This Nutritional Product Direct Seller originally appeared on Fool.com and is written by Anh HOANG.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!